A Clinical Study to Evaluate the Efficacy and Safety of VG2025 in Intrahepatic Cholangiocarcinoma
Virogin Biotech Ltd.
Virogin Biotech Ltd.
Hoffmann-La Roche
Eisai Inc.
Seagen Inc.
SOFIE
Taiho Oncology, Inc.
Merck Sharp & Dohme LLC
Jazz Pharmaceuticals
Incyte Corporation
Merck Sharp & Dohme LLC
RedHill Biopharma Limited
Telix Pharmaceuticals (Innovations) Pty Limited
Lisata Therapeutics, Inc.
3D Medicines
Janssen Research & Development, LLC
Elevation Oncology
Redx Pharma Ltd
Rain Oncology Inc
Virogin Biotech Ltd.
Convalife (Shanghai) Co., Ltd.
CSPC Ouyi Pharmaceutical Co., Ltd.
TransThera Sciences (Nanjing), Inc.
Innovent Biologics (Suzhou) Co. Ltd.
EpicentRx, Inc.
Beijing InnoCare Pharma Tech Co., Ltd.
Basilea Pharmaceutica
Sumitomo Pharma America, Inc.
EMD Serono
PCI Biotech AS
Hoffmann-La Roche
QED Therapeutics, a BridgeBio company
Newish Technology (Beijing) Co., Ltd.
Sorrento Therapeutics, Inc.
Delcath Systems Inc.
Jiangsu HengRui Medicine Co., Ltd.
Hoffmann-La Roche
Criterium, Inc.
Galectin Therapeutics Inc.
Sanofi
BIND Therapeutics